Tetanus Surveillance - United States, 1995-1997

Morbidity and Mortality Weekly Report

Volumn 47, Issue SUPPL. 2, 1998, Pages 1-13

  Bardenheier, Barbara ^a   Prevots, D Rebecca ^a   Khetsuriani, Nino ^a   Wharton, Melinda ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

TETANUS TOXOID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; HEALTH SURVEY; HUMAN; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; TETANUS; UNITED STATES;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; POPULATION SURVEILLANCE; TETANUS; TETANUS TOXOID; UNITED STATES;

EID: 0032479088     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. CDC. Summary of notifiable diseases, United States, 1996. MMWR 1997;45(No. 53):55-61.
2. Taeuber IB. The changing distribution of the population of the United States in the Twentieth Century. In Research reports, Vol V, Population distribution and policy, Mazie SM, ed. Washington, DC: US Bureau of the Census, Commission on Population Growth and the American Future, 1972.
3. CDC. State immunization requirements, 1996-1997. Atlanta, GA: US Department of Health and Human Services, Public Health Service, CDC, 1998.
4. Zell ER, Dietz V, Stevenson J, Cochi S, Bruce RH. Low vaccination levels of US preschool and school-age children: retrospective assessments of vaccination coverage, 1991-1992. JAMA 1994;271:833-9.
5. CDC. Status report on the childhood immunization initiative: national, state, and urban area vaccination coverage levels among children aged 19-35 months - United States, 1996. MMWR 1997;46:657-64.
6. CDC. Case definitions for infectious conditions under public health surveillance. MMWR 1997;46(No. RR-10).
7. Blake PA, Feldman RA, Buchanan TM, Brooks GF, Bennett JV. Serologic therapy of tetanus the United States, 1965-1971. JAMA 1976;235:42-4.
8. CDC. Tetanus - United States, 1982-1984. MMWR 1985;34:602,607-11.
9. CDC. Tetanus - United States, 1985-1986. MMWR 1987;36:477-81.
10. CDC. Tetanus - United States, 1987 and 1988. MMWR 1990;39:37-41.
11. Prevots R, Sutter RW, Strebel PM, Cochi SL, Hadler S. Tetanus surveillance - United States, 1989-1990. In CDC surveillance summaries (December). MMWR 1992;41(No. SS-8):1-9.
12. Izurieta HS, Sutter RW, Strebel PM, et al. Tetanus surveillance - United States, 1991-1994. In CDC surveillance summaries (February). MMWR 1997;46(No. SS-2):15-25.
13. Craig AS, Reed GW, Mohon RT, et al. Neonatal tetanus in the United States: a sentinel event in the foreign-born. Pediatr Infect Dis J 1997;16:955-9.
14. CDC. Tetanus among injecting-drug users - California, 1997. MMWR 1998;47:149-51.
15. CDC. Reported morbidity and mortality in the United States, 1973. MMWR 1974;22:20.
16. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995;332:761-6.
17. ACIP. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures - recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(No. RR-10).
18. Center for Disease Control. Tetanus surveillance: 1970-1971 summary. Atlanta, GA: US Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, March 31, 1974; report no. 4.
19. Cherubin CE, Millian SJ, Palusci E, Fortunato M. Investigations in tetanus in narcotics addicts in New York City. Am J Epidemiol 1968;88:215-23.
20. Cherubin CE. Epidemiology of tetanus in narcotic addicts. N Y State J Med 1970;70:267-71.
21. Sangali M, Chierchini P, Aylward RB, Forastiere F. Tetanus: a rare but preventable cause of mortality among drug users and the elderly. Eur J Epidemiol 1996;12:539-40.
22. Rezza G, Pizzuti R, De Campora E, De Masi S, Vlahov D. Tetanus and injections drug use: rediscovery of a neglected problem? Eur J Epidemiol 1996;12:655-6.
23. Sun KO, Chan YW, Cheung RTF, So PC, Yu YL, Li PCK. Management of tetanus: a review of 18 cases. J R Soc Med 1994;87:135-7.
24. Cilla G, Pérez-Trallero E, Sáenz-Dominguez JR, Esparza H, Otero F. Tetanus immunity among intravenous drug users in Guipuzcoa (Basque Country, Spain). AIDS 1994;8:271-2.
25. Cherubin CE, Sapira JD. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Intern Med 1993;119:1017-28.
26. Reddy MA, ed. Statistical record of Hispanic Americans. Detroit, MI: Gale Research International, 1993.
27. Office of National Drug Control Policy. Pulse check: national trends in drug abuse. Washington, DC: Executive Office of the President, Spring 1995.
28. Bureau of Justice Statistics. Drugs, crime, and the justice system: a national report from the Bureau of Justice Statistics. Washington, DC: US Department of Justice, Office of Justice Programs, Government Printing Office, December 1992; publication no. (NCJ)133652.
29. Passaro DJ, Werner SB, McGee J, Mac Kenzie WR, Vugia DJ. Wound botulism associated with black tar heroin among injecting drug users. JAMA 1998;279:859-63.
30. CDC. Publication of HIV-prevention bulletin for health-care providers regarding advice to persons who inject illicit drugs. MMWR 1997;46:510.
31. ACIP. Update on adult immunization: recommendations of the Immunzation Practices Advisory Committee (ACIP). MMWR 1991;40(No. RR-12).
32. Kumar S, Malecki JM. A case of neonatal tetanus. South Med J 1991;84:396-8.
33. World Health Organization. The "high-risk" approach: the WHO-recommended strategy to accelerate elimination of neonatal tetanus. Wkly Epidemiol Rec 1996;71:33-6.
34. World Health Assembly. Handbook of resolutions and decisions of the World Health Assembly and the Executive Board, vol III. 3rd ed (1985-92). Geneva: World Health Organization, 1993 (Resolution WHA42.32).
35. Hinman AR, Foster SO, Wassilak SGF. Neonatal tetanus: potential for elimination in the world. Pediatr Infect Dis J 1987;6:813-6.
36. Sutter RW, Cochi SL, Brink EW, Sirotkin BL. Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979-1984. Am J Epidemiol 1990;131:132-42.
37. Edmondson RS, Flowers MW. Intensive care in tetanus: management, complications, and mortality in 100 cases. Br Med J 1979;1:1401-4.
38. Humbert G, Fillastre J-P, Dordain M, Leroy J, Robert M, Delauney P. 100 Cases of tetanus. Scand J Infect Dis 1972;4:129-31.
39. Alfery DD, Rauscher LA. Tetanus: a review. Crit Care Med 1979;7:176-81.
40. Edsall G. Specific prophylaxis of tetanus. JAMA 1959;171:121-35.
41. CDC. Recommended childhood immunization schedule - United States, 1998. MMWR 1998;47:8-11.
42. CDC. Assessing adult vaccination status at age 50 years. MMWR 1995;44:561-3.